Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,2,3,4-tetrahydro-2-azanaphthalene
2. 3,4-dihydro-1h-isoquinoline
3. Hcl Of 1,2,3,4-tetrahydroisoquinoline
4. Isoquinoline, 1,2,3,4-tetrahydro-
5. Tetrahydroisoquinoline
1. 91-21-4
2. Tetrahydroisoquinoline
3. 1,2,3,4-tetrahydro-isoquinoline
4. Isoquinoline, 1,2,3,4-tetrahydro-
5. Mfcd00006896
6. 3,4-dihydro-1h-isoquinoline
7. 1,2,3,4-tetrahydro-2-azanaphthalene
8. 1,2,3,4-tetrahydro Isoquinoline
9. 1,2,3,4-tetrahydro-2-isoquinoline
10. Chembl14346
11. 56w89fbx3e
12. Nsc-15312
13. Tetrahydro-isoquinoline
14. Einecs 202-050-0
15. Nsc 15312
16. Brn 0116156
17. Ai3-15931
18. Tetrahyroisoquinoline
19. Dsstox_cid_6115
20. Thiq 6
21. Ec 202-050-0
22. Dsstox_rid_78022
23. Unii-56w89fbx3e
24. Dsstox_gsid_26115
25. Racemic Tetrahydroisoquinoline
26. Schembl19085
27. Wln: T66 Cmt&j
28. 5-20-06-00320 (beilstein Handbook Reference)
29. 1,3,4-tetrahydroisoquinoline
30. 1,2,3,4-tetrahydroleucoline
31. 3,4-dihydro-1 H-isoquinoline
32. Dtxsid6026115
33. 1,2,3,4 Tetrahydroisoquinoline
34. 1,2,3,4-tetrahydroisochinoline
35. 1,2.3.4-tetrahydroisoquinoline
36. Bdbm13016
37. Chebi:125498
38. 1,2,3,4- Tetrahydroisoquinoline
39. 1,2,3,4-?tetrahydroisoquinoline
40. 1,2,3,4-tetra-hydroisoquinoline
41. 1,2,3,4,-tetrahydro-isoquinoline
42. 1,2,3,4-tetrahydro-iso-quinoline
43. Act05258
44. Nsc15312
45. Zinc3860771
46. Tox21_200374
47. 1, 2, 3, 4-tetrahydroisoquinoline
48. Stl182848
49. 1, 2, 3, 4 Tetrahydroisoquinoline
50. 1, 2, 3, 4-tetrahydro-isoquinoline
51. Akos000119066
52. Cs-w002013
53. 1,2,3,4-tetrahydroisoquinoline, 95%
54. Cas-91-21-4
55. Ncgc00091283-01
56. Ncgc00091283-02
57. Ncgc00257928-01
58. Sy001156
59. Ts-01726
60. Db-005616
61. Ft-0600443
62. T1676
63. L001004
64. Q411677
65. Q-102336
66. W-100315
67. Brd-k18436203-001-01-4
68. Z57834231
69. F2190-0352
70. 2ck
Molecular Weight | 133.19 g/mol |
---|---|
Molecular Formula | C9H11N |
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Exact Mass | 133.089149355 g/mol |
Monoisotopic Mass | 133.089149355 g/mol |
Topological Polar Surface Area | 12 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 111 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tetrahydroisoquinolin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tetrahydroisoquinolin, including repackagers and relabelers. The FDA regulates Tetrahydroisoquinolin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tetrahydroisoquinolin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tetrahydroisoquinolin supplier is an individual or a company that provides Tetrahydroisoquinolin active pharmaceutical ingredient (API) or Tetrahydroisoquinolin finished formulations upon request. The Tetrahydroisoquinolin suppliers may include Tetrahydroisoquinolin API manufacturers, exporters, distributors and traders.
click here to find a list of Tetrahydroisoquinolin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tetrahydroisoquinolin DMF (Drug Master File) is a document detailing the whole manufacturing process of Tetrahydroisoquinolin active pharmaceutical ingredient (API) in detail. Different forms of Tetrahydroisoquinolin DMFs exist exist since differing nations have different regulations, such as Tetrahydroisoquinolin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tetrahydroisoquinolin DMF submitted to regulatory agencies in the US is known as a USDMF. Tetrahydroisoquinolin USDMF includes data on Tetrahydroisoquinolin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tetrahydroisoquinolin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tetrahydroisoquinolin suppliers with USDMF on PharmaCompass.
Tetrahydroisoquinolin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tetrahydroisoquinolin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tetrahydroisoquinolin GMP manufacturer or Tetrahydroisoquinolin GMP API supplier for your needs.
A Tetrahydroisoquinolin CoA (Certificate of Analysis) is a formal document that attests to Tetrahydroisoquinolin's compliance with Tetrahydroisoquinolin specifications and serves as a tool for batch-level quality control.
Tetrahydroisoquinolin CoA mostly includes findings from lab analyses of a specific batch. For each Tetrahydroisoquinolin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tetrahydroisoquinolin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tetrahydroisoquinolin EP), Tetrahydroisoquinolin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tetrahydroisoquinolin USP).
LOOKING FOR A SUPPLIER?